Feb 24, 2021 / 02:50PM GMT
Patrick Bernard Donnelly - Citigroup Inc., Research Division - Senior Analyst
Hey, good morning. I'm Patrick Donnelly, the tools and diagnostics analyst here at Citi. Happy to have Jeff Elliott, the CFO of Exact Sciences, with us today to kind of keep the conference going.
Jeff, thanks for being here. And I think maybe just to start, you guys obviously reported results just last week, a lot of moving pieces with kind of coming out of COVID and kind of getting into '21. So maybe I'll turn it over to you for just a quick lay of the land, how things trended in 4Q. And then we can dive into some questions.
Jeffrey T. Elliott - Exact Sciences Corporation - CFO
Patrick, thanks for having us. Great to see you again. Hopefully, we could do this again in person sometime soon.
For those of you who don't know us as well as Patrick, Exact Sciences is a company focused on the early detection and prevention of cancer. Our 2 flagship products are Cologuard, which is for colon cancer screening; and Oncotype DX, which is a prognostic test to help women and men
Exact Sciences Corp at Citi Healthcare Services, Medtech, Tools, & HCIT Virtual Conference Transcript
Feb 24, 2021
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers